Fleming, Andrew
Galey, Miranda
Briggs, Lizi
Edwards, Matthew http://orcid.org/0000-0002-8477-530X
Hogg, Claire http://orcid.org/0000-0002-8368-5994
John, Shibu
Wilkinson, Sam
Quinn, Ellie http://orcid.org/0000-0003-3648-6084
Rai, Ranjit
Burgoyne, Tom
Rogers, Andy
Patel, Mitali P.
Griffin, Paul
Muller, Steven
Carr, Siobhan B. http://orcid.org/0000-0003-0580-2478
Loebinger, Michael R.
Lucas, Jane S. http://orcid.org/0000-0001-8701-9975
Shah, Anand
Jose, Ricardo
Mitchison, Hannah M. http://orcid.org/0000-0002-3163-6293
Shoemark, Amelia
Miller, Danny E. http://orcid.org/0000-0001-6096-8601
Morris-Rosendahl, Deborah J. http://orcid.org/0000-0002-7780-4707
Article History
Received: 11 December 2023
Revised: 8 March 2024
Accepted: 18 March 2024
First Online: 11 April 2024
Competing interests
: DEM is on a scientific advisory board at ONT, is engaged in a research agreement with ONT, and they have paid for him to travel to speak on their behalf. DEM holds stock options in MyOme.
: All participating institutions received approval from local institutional review boards. Informed consent was obtained from all subjects, and any clinical data has been de-identified.